Your browser doesn't support javascript.
loading
Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor-Mediated Recycling of HL2351, a Novel Hybrid Fc-Fused Interleukin-1 Receptor Antagonist, to Optimize Dosage Regimen.
Ngo, Lien; Oh, Jaeseong; Kim, Anhye; Back, Hyun-Moon; Kang, Won-Ho; Chae, Jung-Woo; Yun, Hwi-Yeol; Lee, Howard.
Afiliação
  • Ngo L; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.
  • Oh J; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
  • Kim A; Department of Clinical Pharmacology and Therapeutics, CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-do, Republic of Korea.
  • Back HM; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jeresy, USA.
  • Kang WH; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.
  • Chae JW; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.
  • Yun HY; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.
  • Lee H; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
CPT Pharmacometrics Syst Pharmacol ; 9(10): 584-595, 2020 10.
Article em En | MEDLINE | ID: mdl-32945613
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Receptores Fc / Antígenos de Histocompatibilidade Classe I / Antirreumáticos / Proteína Antagonista do Receptor de Interleucina 1 Limite: Adult / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Receptores Fc / Antígenos de Histocompatibilidade Classe I / Antirreumáticos / Proteína Antagonista do Receptor de Interleucina 1 Limite: Adult / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article